Exact Mass: 520.2705894000001
Exact Mass Matches: 520.2705894000001
Found 500 metabolites which its exact mass value is equals to given mass value 520.2705894000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7beta-hydroxytaxusin
A taxane diterpenoid that is taxusin in which the hydrogen at the 7beta position is replaced by a hydroxy group.
Dolichol diphosphate
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is a constituent of quince (Cydonia vulgaris) leaves
Withaperuvin D
Withaperuvin D is found in fruits. Withaperuvin D is a constituent of leaves of Physalis peruviana (Cape gooseberry) Constituent of leaves of Physalis peruviana (Cape gooseberry). Withaperuvin D is found in fruits.
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
rac-4-Hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate
This compound belongs to the family of Diterpene Glycosides. These are diterpenes in which an isoprene unit is glycosylated.
Nastorazepide
Caseanigrescen B
A diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line.
(6R,9R)-9-Hydroxy-4-megastigmen-3-one 9-O-??-D-glucopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
Withaperuvin B
neocynapanogenin C 3-O-beta-D-oleandroside|paniculatumoside B
methyl-ent-7alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha,15alpha-dihydroxykaur-16-en-19-oate|methyl-ent-7alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha,15alpha-dihydroxykaur-16-en-19-oate
14-Hydroxy-3beta-(O3-methyl-beta-D-fucopyranosyloxy)-14beta-pregn-5-en-11,15,20-trion|14-hydroxy-3beta-(O3-methyl-beta-D-fucopyranosyloxy)-14beta-pregn-5-ene-11,15,20-trione
(3R,3aR,4S,11aR,13bS)-1,2,3,3a,4,5,9,11,11a,13b-decahydro-3a,11,11,13b-tetramethyl-3-{(1S)-1-[(2S)-3,6-dihydro-5-methyl-6-oxo-2H-pyran-2-yl]ethyl}-9-oxoindeo[5,4:4,5]cyclohepta[1,2-c]oxepin-4-yl acetate|heteroclitalactone G|polysperlactone A
5alpha,9alpha,10beta,13alpha-tetraacetoxy-11(15->1)abeotaxa-4(20),11-dien-15-ol|5alpha,9alpha,10beta,13alpha-tetraacetoxy-15-hydroxy-11(15->1)-abeo-taxa-4(20),11-diene|5??,9??,10??,13??-Tetraacetoxy-15-hydroxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene
(1R,2R,3R,4R,5S,7R,9S,10R)-1-benzoyloxy-9-cinnamoyloxy-2,3-dihydroxydihydro-beta-agarofuran
1beta-benzoyl-8alpha-cinnamoyl-4alpha,5alpha-dihydroxydihydroagarofuran
(3R,9S)-megastigman-5-ene-3,9-diol 9-O-alpha-L-rhamnopyranosyl-(1?2)-beta-D-glucopyranoside|pteleifoside B
3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3-O-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|3alpha,6alpha-dihydroxymegastigman-7-en-9-one-3-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
2-(2,4,5-Trihydroxyphenyl)-3,6,8-tris(3-methyl-2-butenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one
3-hydroxy-5,6-epoxy-beta-ionol-3-O-beta-apiofuranosyl-(1->6)-beta-glucopyranoside
5R,6S,7E-megastigma-3-on-7-en-9-ol 9-O-beta-D-(6-O-beta-D-xylopyranosyl)glucopyranoside|ampelopsisionoside 6-O-beta-D-xylopyranoside|platanionoside C
5,7-Dihydroxy-6-methyl-2-phenyl-8-[1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxo-1-cyclohexenyl)-3-methylbutyl]-2H-1-benzopyran-4(3H)-one
13-hydroxyblumenol C apiosylglucoside|4-[3-(2-O-beta-apiofuranosyl-beta-glucopyranosyloxy)-butyl]-3-(hydroxymethyl)-5,5-dimethyl-2-cyclohexen-1-one
1-(3-Methoxy-4-hydroxyphenyl)-1-methoxy-2,3-bis(2-methoxy-4-allylphenoxy)propane
(20S,22S,23S,24S,25S,26S)-12alpha,22,23,26,24,25-triepoxy-5alpha,6beta,12beta,17beta,26-pentahydroxyergosta-2-en-1-one|jaborosalactol 27
(1S*,2S*,5Z,7S*,8R*,9S*,10S*,11R*,12R*,17R*)-2,9-diacetoxy-12-butanoyloxy-8-hydroxybriara-5,13-dien-18-one|cavernulin A
Phe Gln Ala Arg
2alpha-hydroxytaxusin
A taxane diterpenoid that is taxusin substituted by a hydroxy group at position 2alpha.
1b-Benzoyl-8a-cinnamoyl-4a,5a-dihydroxydihydroagarofuran
Glaucoside A
Glaucoside A is a natural product found in Vincetoxicum amplexicaule with data available.
C24H40O12_(2R,3E)-4-[(1S,6R)-1-Hydroxy-2,2,6-trimethyl-4-oxocyclohexyl]-3-buten-2-yl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
C28H40O9_1(2H)-Naphthalenone, 2,7-bis(acetyloxy)-4-[(3E)-2,5-bis(acetyloxy)-3-methyl-3-penten-1-yl]octahydro-4a,8,8-trimethyl-3-methylene
Ala Phe Gln Arg
Ala Phe Arg Gln
Ala Gln Phe Arg
Ala Gln Arg Phe
Ala Arg Phe Gln
Ala Arg Gln Phe
Cys Arg Arg Ser
Cys Arg Ser Arg
Cys Ser Arg Arg
Asp Lys Lys Met
Asp Lys Met Lys
Asp Met Lys Lys
Glu Phe Ile Ile
Glu Phe Ile Leu
Glu Phe Leu Ile
Glu Phe Leu Leu
Glu Ile Phe Ile
Glu Ile Phe Leu
Glu Ile Ile Phe
Glu Ile Leu Phe
Glu Ile Pro Tyr
Glu Ile Tyr Pro
Glu Leu Phe Ile
Glu Leu Phe Leu
Glu Leu Ile Phe
Glu Leu Leu Phe
Glu Leu Pro Tyr
Glu Leu Tyr Pro
Glu Pro Ile Tyr
Glu Pro Leu Tyr
Glu Pro Tyr Ile
Glu Pro Tyr Leu
Glu Tyr Ile Pro
Glu Tyr Leu Pro
Glu Tyr Pro Ile
Glu Tyr Pro Leu
Phe Ala Phe His
Phe Ala His Phe
Phe Ala Gln Arg
Phe Ala Arg Gln
Phe Glu Ile Ile
Phe Glu Ile Leu
Phe Glu Leu Ile
Phe Glu Leu Leu
Phe His Phe Ala
Phe Ile Glu Ile
Phe Ile Glu Leu
Phe Ile Ile Glu
Phe Ile Leu Glu
Phe Ile Asn Gln
C24H36N6O7 (520.2645345999999)
Phe Ile Gln Asn
C24H36N6O7 (520.2645345999999)
Phe Leu Glu Ile
Phe Leu Glu Leu
Phe Leu Ile Glu
Phe Leu Leu Glu
Phe Leu Asn Gln
C24H36N6O7 (520.2645345999999)
Phe Leu Gln Asn
C24H36N6O7 (520.2645345999999)
Phe Asn Ile Gln
C24H36N6O7 (520.2645345999999)
Phe Asn Leu Gln
C24H36N6O7 (520.2645345999999)
Phe Asn Gln Ile
C24H36N6O7 (520.2645345999999)
Phe Asn Gln Leu
C24H36N6O7 (520.2645345999999)
Phe Gln Ile Asn
C24H36N6O7 (520.2645345999999)
Phe Gln Leu Asn
C24H36N6O7 (520.2645345999999)
Phe Gln Asn Ile
C24H36N6O7 (520.2645345999999)
Phe Gln Asn Leu
C24H36N6O7 (520.2645345999999)
Phe Gln Gln Val
C24H36N6O7 (520.2645345999999)
Phe Gln Arg Ala
Phe Gln Val Gln
C24H36N6O7 (520.2645345999999)
Phe Arg Ala Gln
Phe Arg Gln Ala
Phe Val Gln Gln
C24H36N6O7 (520.2645345999999)
Gly Lys Met Trp
Gly Lys Trp Met
Gly Met Lys Trp
Gly Met Trp Lys
Gly Trp Lys Met
Gly Trp Met Lys
His Ala Phe Phe
His Phe Ala Phe
His Phe Phe Ala
Ile Glu Phe Ile
Ile Glu Phe Leu
Ile Glu Ile Phe
Ile Glu Leu Phe
Ile Glu Pro Tyr
Ile Glu Tyr Pro
Ile Phe Glu Ile
Ile Phe Glu Leu
Ile Phe Ile Glu
Ile Phe Leu Glu
Ile Phe Asn Gln
C24H36N6O7 (520.2645345999999)
Ile Phe Gln Asn
C24H36N6O7 (520.2645345999999)
Ile Ile Glu Phe
Ile Ile Phe Glu
Ile Leu Glu Phe
Ile Leu Phe Glu
Ile Asn Phe Gln
C24H36N6O7 (520.2645345999999)
Ile Asn Gln Phe
C24H36N6O7 (520.2645345999999)
Ile Pro Glu Tyr
Ile Pro Tyr Glu
Ile Gln Phe Asn
C24H36N6O7 (520.2645345999999)
Ile Gln Asn Phe
C24H36N6O7 (520.2645345999999)
Ile Tyr Glu Pro
Ile Tyr Pro Glu
Lys Asp Lys Met
Lys Asp Met Lys
Lys Gly Met Trp
Lys Gly Trp Met
Lys Lys Asp Met
Lys Lys Met Asp
Lys Met Asp Lys
Lys Met Gly Trp
Lys Met Lys Asp
Lys Met Arg Ser
Lys Met Ser Arg
Lys Met Trp Gly
Lys Asn Pro Tyr
C24H36N6O7 (520.2645345999999)
Lys Asn Tyr Pro
C24H36N6O7 (520.2645345999999)
Lys Pro Asn Tyr
C24H36N6O7 (520.2645345999999)
Lys Pro Tyr Asn
C24H36N6O7 (520.2645345999999)
Lys Arg Met Ser
Lys Arg Ser Met
Lys Ser Met Arg
Lys Ser Arg Met
Lys Ser Thr Trp
C24H36N6O7 (520.2645345999999)
Lys Ser Trp Thr
C24H36N6O7 (520.2645345999999)
Lys Thr Ser Trp
C24H36N6O7 (520.2645345999999)
Lys Thr Trp Ser
C24H36N6O7 (520.2645345999999)
Lys Trp Gly Met
Lys Trp Met Gly
Lys Trp Ser Thr
C24H36N6O7 (520.2645345999999)
Lys Trp Thr Ser
C24H36N6O7 (520.2645345999999)
Lys Tyr Asn Pro
C24H36N6O7 (520.2645345999999)
Lys Tyr Pro Asn
C24H36N6O7 (520.2645345999999)
Leu Glu Phe Ile
Leu Glu Phe Leu
Leu Glu Ile Phe
Leu Glu Leu Phe
Leu Glu Pro Tyr
Leu Glu Tyr Pro
Leu Phe Glu Ile
Leu Phe Glu Leu
Leu Phe Ile Glu
Leu Phe Leu Glu
Leu Phe Asn Gln
C24H36N6O7 (520.2645345999999)
Leu Phe Gln Asn
C24H36N6O7 (520.2645345999999)
Leu Ile Glu Phe
Leu Ile Phe Glu
Leu Leu Glu Phe
Leu Leu Phe Glu
Leu Asn Phe Gln
C24H36N6O7 (520.2645345999999)
Leu Asn Gln Phe
C24H36N6O7 (520.2645345999999)
Leu Pro Glu Tyr
Leu Pro Tyr Glu
Leu Gln Phe Asn
C24H36N6O7 (520.2645345999999)
Leu Gln Asn Phe
C24H36N6O7 (520.2645345999999)
Leu Tyr Glu Pro
Leu Tyr Pro Glu
Met Asp Lys Lys
Met Gly Lys Trp
Met Gly Trp Lys
Met Lys Asp Lys
Met Lys Gly Trp
Met Lys Lys Asp
Met Lys Arg Ser
Met Lys Ser Arg
Met Lys Trp Gly
Met Arg Lys Ser
Met Arg Ser Lys
Met Ser Lys Arg
Met Ser Arg Lys
Met Trp Gly Lys
Met Trp Lys Gly
Asn Phe Ile Gln
C24H36N6O7 (520.2645345999999)
Asn Phe Leu Gln
C24H36N6O7 (520.2645345999999)
Asn Phe Gln Ile
C24H36N6O7 (520.2645345999999)
Asn Phe Gln Leu
C24H36N6O7 (520.2645345999999)
Asn Ile Phe Gln
C24H36N6O7 (520.2645345999999)
Asn Ile Gln Phe
C24H36N6O7 (520.2645345999999)
Asn Lys Pro Tyr
C24H36N6O7 (520.2645345999999)
Asn Lys Tyr Pro
C24H36N6O7 (520.2645345999999)
Asn Leu Phe Gln
C24H36N6O7 (520.2645345999999)
Asn Leu Gln Phe
C24H36N6O7 (520.2645345999999)
Asn Pro Lys Tyr
C24H36N6O7 (520.2645345999999)
Asn Pro Tyr Lys
C24H36N6O7 (520.2645345999999)
Asn Gln Phe Ile
C24H36N6O7 (520.2645345999999)
Asn Gln Phe Leu
C24H36N6O7 (520.2645345999999)
Asn Gln Ile Phe
C24H36N6O7 (520.2645345999999)
Asn Gln Leu Phe
C24H36N6O7 (520.2645345999999)
Asn Tyr Lys Pro
C24H36N6O7 (520.2645345999999)
Asn Tyr Pro Lys
C24H36N6O7 (520.2645345999999)
Pro Glu Ile Tyr
Pro Glu Leu Tyr
Pro Glu Tyr Ile
Pro Glu Tyr Leu
Pro Ile Glu Tyr
Pro Ile Tyr Glu
Pro Lys Asn Tyr
C24H36N6O7 (520.2645345999999)
Pro Lys Tyr Asn
C24H36N6O7 (520.2645345999999)
Pro Leu Glu Tyr
Pro Leu Tyr Glu
Pro Asn Lys Tyr
C24H36N6O7 (520.2645345999999)
Pro Asn Tyr Lys
C24H36N6O7 (520.2645345999999)
Pro Tyr Glu Ile
Pro Tyr Glu Leu
Pro Tyr Ile Glu
Pro Tyr Lys Asn
C24H36N6O7 (520.2645345999999)
Pro Tyr Leu Glu
Pro Tyr Asn Lys
C24H36N6O7 (520.2645345999999)
Gln Ala Phe Arg
Gln Ala Arg Phe
Gln Phe Ala Arg
Gln Phe Ile Asn
C24H36N6O7 (520.2645345999999)
Gln Phe Leu Asn
C24H36N6O7 (520.2645345999999)
Gln Phe Asn Ile
C24H36N6O7 (520.2645345999999)
Gln Phe Asn Leu
C24H36N6O7 (520.2645345999999)
Gln Phe Gln Val
C24H36N6O7 (520.2645345999999)
Gln Phe Arg Ala
Gln Phe Val Gln
C24H36N6O7 (520.2645345999999)
Gln Ile Phe Asn
C24H36N6O7 (520.2645345999999)
Gln Ile Asn Phe
C24H36N6O7 (520.2645345999999)
Gln Leu Phe Asn
C24H36N6O7 (520.2645345999999)
Gln Leu Asn Phe
C24H36N6O7 (520.2645345999999)
Gln Asn Phe Ile
C24H36N6O7 (520.2645345999999)
Gln Asn Phe Leu
C24H36N6O7 (520.2645345999999)
Gln Asn Ile Phe
C24H36N6O7 (520.2645345999999)
Gln Asn Leu Phe
C24H36N6O7 (520.2645345999999)
Gln Gln Phe Val
C24H36N6O7 (520.2645345999999)
Gln Gln Val Phe
C24H36N6O7 (520.2645345999999)
Gln Arg Ala Phe
Gln Arg Phe Ala
Gln Val Phe Gln
C24H36N6O7 (520.2645345999999)
Gln Val Gln Phe
C24H36N6O7 (520.2645345999999)
Arg Ala Phe Gln
Arg Ala Gln Phe
Arg Cys Arg Ser
Arg Cys Ser Arg
Arg Phe Ala Gln
Arg Phe Gln Ala
Arg Lys Met Ser
Arg Lys Ser Met
Arg Met Lys Ser
Arg Met Ser Lys
Arg Gln Ala Phe
Arg Gln Phe Ala
Arg Arg Cys Ser
Arg Arg Ser Cys
Arg Ser Cys Arg
Arg Ser Lys Met
Arg Ser Met Lys
Arg Ser Arg Cys
Ser Cys Arg Arg
Ser Lys Met Arg
Ser Lys Arg Met
Ser Lys Thr Trp
C24H36N6O7 (520.2645345999999)
Ser Lys Trp Thr
C24H36N6O7 (520.2645345999999)
Ser Met Lys Arg
Ser Met Arg Lys
Ser Arg Cys Arg
Ser Arg Lys Met
Ser Arg Met Lys
Ser Arg Arg Cys
Ser Thr Lys Trp
C24H36N6O7 (520.2645345999999)
Ser Thr Trp Lys
C24H36N6O7 (520.2645345999999)
Ser Trp Lys Thr
C24H36N6O7 (520.2645345999999)
Ser Trp Thr Lys
C24H36N6O7 (520.2645345999999)
Thr Lys Ser Trp
C24H36N6O7 (520.2645345999999)
Thr Lys Trp Ser
C24H36N6O7 (520.2645345999999)
Thr Ser Lys Trp
C24H36N6O7 (520.2645345999999)
Thr Ser Trp Lys
C24H36N6O7 (520.2645345999999)
Thr Trp Lys Ser
C24H36N6O7 (520.2645345999999)
Thr Trp Ser Lys
C24H36N6O7 (520.2645345999999)
Val Phe Gln Gln
C24H36N6O7 (520.2645345999999)
Val Gln Phe Gln
C24H36N6O7 (520.2645345999999)
Val Gln Gln Phe
C24H36N6O7 (520.2645345999999)
Trp Gly Lys Met
Trp Gly Met Lys
Trp Lys Gly Met
Trp Lys Met Gly
Trp Lys Ser Thr
C24H36N6O7 (520.2645345999999)
Trp Lys Thr Ser
C24H36N6O7 (520.2645345999999)
Trp Met Gly Lys
Trp Met Lys Gly
Trp Ser Lys Thr
C24H36N6O7 (520.2645345999999)
Trp Ser Thr Lys
C24H36N6O7 (520.2645345999999)
Trp Thr Lys Ser
C24H36N6O7 (520.2645345999999)
Trp Thr Ser Lys
C24H36N6O7 (520.2645345999999)
Tyr Glu Ile Pro
Tyr Glu Leu Pro
Tyr Glu Pro Ile
Tyr Glu Pro Leu
Tyr Ile Glu Pro
Tyr Ile Pro Glu
Tyr Lys Asn Pro
C24H36N6O7 (520.2645345999999)
Tyr Lys Pro Asn
C24H36N6O7 (520.2645345999999)
Tyr Leu Glu Pro
Tyr Leu Pro Glu
Tyr Asn Lys Pro
C24H36N6O7 (520.2645345999999)
Tyr Asn Pro Lys
C24H36N6O7 (520.2645345999999)
Tyr Pro Glu Ile
Tyr Pro Glu Leu
Tyr Pro Ile Glu
Tyr Pro Lys Asn
C24H36N6O7 (520.2645345999999)
Tyr Pro Leu Glu
Tyr Pro Asn Lys
C24H36N6O7 (520.2645345999999)
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2 / 26,26,26,27,27,27-hexafluoro-25-hydroxyergocalciferol
C28H38F6O2 (520.2775839999999)
25-Hydroxyvitamin D3-bromoacetate
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
Withaperuvin D
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
PCTR2
C27H40N2O6S (520.2606940000001)
MCTR2
C27H40N2O6S (520.2606940000001)
Withaperuvin
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2
C28H38F6O2 (520.2775839999999)
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2
C28H38O2F6 (520.2775839999999)
25-Hydroxyvitamin D3-bromoacetate
Gallopamil hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
di-n-butyltin bis(2-ethylhexanoate)
C24H48O4Sn (520.2574397999999)
Nastorazepide
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target:CCK-2 in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice.
1,2-Ethanediamine, N1-(3-(trimethoxysilyl)propyl)-, N-((ethenylphenyl)methyl) derivs., hydrochlorides, hydrolyzed
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid
C27H40N2O6S (520.2606940000001)
Nastorazepide
7beta-Hydroxytaxa-4(20),11-diene-5alpha,9alpha,10beta,13alpha-tetrayl tetraacetate
5-(2-amino-1-hydroxyethyl)-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-(3,6-diaminohexanoylamino)-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid
(2-Methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1-biphenyl]-4-yl)(1-methyl-6,7-dihydrospiro[furo[2,3-f]indole-3,4-piperidin]-5(2H)-yl)methanone
2-Hydroxy-2alpha,5alpha,9alpha,10beta,13alpha-taxa-4(20),11-diene-5,9,10,13-tetrayl tetraacetate
S-[(3Z,6R,7S,15Z,18Z)-21-carboxy-6-hydroxyhenicosa-3,8,10,12,15,18-hexaen-7-yl]-L-cysteinylglycine
C27H40N2O6S (520.2606940000001)
3-[(3aS,10bS)-2-[4-(3-hydroxypropoxy)phenyl]-4-oxo-5-prop-2-enyl-6,10b-dihydrooxazolo[4,5-d][2]benzazepin-3a-yl]propanoic acid tert-butyl ester
C30H36N2O6 (520.2573236000001)
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
2-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
C27H40N2O6S (520.2606940000001)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[(5-phenyl-3-isoxazolyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
methyl 6-{[4,6-dideoxy-3-O-(4,6-dideoxy-4-formamido-2,3-di-O-methyl-alpha-D-mannopyranosyl)-4-formamido-alpha-D-mannopyranosyl]oxy}hexanoate
(3S,6S)-3,4,5-trihydroxy-6-[[(1S,2S,10S,13R,14S,17S,18S)-17-hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-5-yl]oxy]oxane-2-carboxylic acid
(4S,5S)-5-[(1R)-2-amino-1-hydroxyethyl]-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-[[(3S)-3,6-diaminohexanoyl]amino]-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1Z,4S,12R,14S,17Z)-12-hydroxy-19,19-dimethyl-7-(3-methylbut-2-enyl)-3,5,16,21-tetrazaheptacyclo[14.13.0.03,14.04,12.06,11.020,28.022,27]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
(1Z,4R,5S,14S,16S,19Z)-14-hydroxy-5,6,6,21,21-pentamethyl-3,7,18,23-tetrazaoctacyclo[16.13.0.03,16.04,7.04,14.08,13.022,30.024,29]hentriaconta-1(31),8,10,12,19,22(30),24,26,28-nonaene-2,17-dione
rac-4-Hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate
(13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
C27H40N2O6S (520.2606940000001)
A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 13R via a sulfide linkage.
16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
C27H40N2O6S (520.2606940000001)
A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialized proresolving mediators
SB 224289
A member of the class of benzamides obtained by formal condensation of the carboxy group of 2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid with the secondary amino group of 1-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4-piperidine]. Selective 5-HT1B receptor antagonist (pKi = 8.2). Displays >60-fold selectivity over 5-HT1D, 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A and 5-HT2C receptors in radioligand binding and functional assays. Centrally active following oral administration in vivo.